Epidemiology of fractures in children with cerebral palsy: a Swedish population-based registry study

Gustaf Linton1, Gunnar Hägglund2, Tomasz Czuba1

  • 1Faculty of Medicine, Lund University, Lund, Sweden.

Insights

Children with cerebral palsy (CP) face similar fracture risks as peers, but epilepsy significantly increases this danger. Fracture locations vary by Gross Motor Function Classification System (GMFCS) level, with femur fractures common in severe cases.

Area of Science:

  • Pediatric Orthopedics
  • Neurology
  • Epidemiology

Background:

  • Children with cerebral palsy (CP) present diverse fracture risks and sites compared to typically developing children.
  • Understanding these epidemiological differences is crucial for targeted prevention and care.

Purpose of the Study:

  • To analyze the epidemiology of fractures in a comprehensive population of children with CP.
  • To identify risk factors and common fracture sites in children with CP.

Main Methods:

  • Retrospective registry study using data from the Swedish Cerebral Palsy Follow-Up Program (CPUP) and the Swedish National Patient Register.
  • Inclusion of children with CP born between 2000-2015, recording Gross Motor Function Classification System (GMFCS) level, fractures, fracture sites, and epilepsy diagnosis up to 2018.
  • Calculation of hazards and hazard ratios for first-time fractures.

Main Results:

  • Out of 3,902 children with CP, 9.4% experienced at least one fracture before age 16.
  • The hazard for fracture was seven times higher in children with epilepsy.
  • Fracture incidence was not significantly linked to sex or GMFCS level, but fracture sites varied: upper extremities in lower GMFCS levels, femur in GMFCS level V.

Conclusions:

  • Children with CP have a similar overall fracture risk to typically developing children, but comorbid epilepsy elevates this risk.
  • Fracture patterns differ by GMFCS level; upper extremity fractures are common in lower GMFCS levels, while lower extremity and femur fractures are more prevalent in higher GMFCS levels (IV-V) and in those with epilepsy.
Abstract